Risks for influenza- and pertussis-related hospitalization, ED visits lower in infants younger than 6 months among those born to mothers who received vaccines.

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

Mavacamten is a selective, reversible, allosteric cardiac myosin inhibitor. It is approved under the brand name Camzyos ® for the treatment of adults with symptomatic New York Heart Association class ...

Nutrition professionals involved in few studies incorporating nutritional interventions or dietary assessments.

All standard over-the-counter and FDA-approved therapies for constipation should be trialed, followed by trials of off-label prescription agents ...

Risk for overall, breast, and prostate cancer increased in association with higher intake of several preservatives.

Mass spectrometry testing should be considered for specific patients or when results could affect downstream care.

HealthDay News — Children conceived via assisted reproductive technology (ART) have a higher risk for developing atopic disease, according to a study published online December 30 in JAMA Network Open.

HealthDay News — Very young children seen virtually for primary care sick visits are more likely to visit the emergency department within three days, according to a study published online December 18 ...

The B-Well 1 and B-Well 2 trials evaluated the safety, efficacy, and durability of bepirovirsen in nucleos(t)ide analogue-treated participants with CHB.

Atacicept is a recombinant fusion protein that binds to and inhibits the activity of BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand).

In May, the US Food and Drug Administration (FDA) approved the first at-home cervical cancer screening tool, developed by Teal Health. The wand allows patients to collect a vaginal sample themselves ...